Skip to main content

Table 1 Demographic and clinical characteristics of patients enrolled in the open-label extension

From: Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia

Parameter

Value (Number = 560)

Age, years

 

  Mean (SD)

46.9 (10.8)

  ≥ 65 years, number (%)

23 (4.1)

Sex, number (%)

 

  Male

50 (8.9)

  Female

510 (91.1)

Race, number (%)

 

  White

512 (91.4)

  Black

34 (6.1)

  Asian

6 (1.1)

  Other

8 (1.4)

BMI, kg/m2

 

  Mean (SD)

28.4 (4.6)

  Range

16.4–41.5

Years since first FM symptoms

 

  Mean (SD)

9.9 (8.7)

Double-blind baseline values, mean (SD)

 

  Pain VAS

72.0 (13.3)

  Fatigue VAS

73.1 (14.8)

  FIQ total score

62.4 (14.1)

  1. BMI, body mass index; FIQ, Fibromyalgia Impact Questionnaire; FM, fibromyalgia syndrome; SD, standard deviation; VAS, visual analog scale.